SE7702547L - Forfarande for framstellning av 3,7-disubstituerade 3-cefem-4-karboxylsyraforeningar - Google Patents

Forfarande for framstellning av 3,7-disubstituerade 3-cefem-4-karboxylsyraforeningar

Info

Publication number
SE7702547L
SE7702547L SE7702547A SE7702547A SE7702547L SE 7702547 L SE7702547 L SE 7702547L SE 7702547 A SE7702547 A SE 7702547A SE 7702547 A SE7702547 A SE 7702547A SE 7702547 L SE7702547 L SE 7702547L
Authority
SE
Sweden
Prior art keywords
cefem
disubstituted
preparing
procedure
carboxylic acid
Prior art date
Application number
SE7702547A
Other languages
Unknown language ( )
English (en)
Other versions
SE437832B (sv
Inventor
T Kamiya
K Tanaka
Y Nakai
K Sakane
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9425/76A external-priority patent/GB1575803A/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of SE7702547L publication Critical patent/SE7702547L/sv
Publication of SE437832B publication Critical patent/SE437832B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/50—Nitrogen atoms bound to hetero atoms
    • C07D277/52—Nitrogen atoms bound to hetero atoms to sulfur atoms, e.g. sulfonamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7702547A 1976-03-09 1977-03-07 Forfarande for framstellning av 3,7-disubstituerade-3-cefem-4-karboxylsyraforeningar SE437832B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9425/76A GB1575803A (en) 1976-03-09 1976-03-09 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof
GB4114576 1976-10-04

Publications (2)

Publication Number Publication Date
SE7702547L true SE7702547L (sv) 1977-09-10
SE437832B SE437832B (sv) 1985-03-18

Family

ID=26242927

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7702547A SE437832B (sv) 1976-03-09 1977-03-07 Forfarande for framstellning av 3,7-disubstituerade-3-cefem-4-karboxylsyraforeningar
SE8302027A SE454988B (sv) 1976-03-09 1983-04-12 (2 ev. sub. amino -1,3-tiazol-5-yl)-glyoxylsyra derivat till anvendning som mellanprodukt till motsvarande cefalosporinsyror

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8302027A SE454988B (sv) 1976-03-09 1983-04-12 (2 ev. sub. amino -1,3-tiazol-5-yl)-glyoxylsyra derivat till anvendning som mellanprodukt till motsvarande cefalosporinsyror

Country Status (10)

Country Link
US (1) US4560765A (sv)
AR (2) AR218241A1 (sv)
CA (1) CA1218054A (sv)
DE (1) DE2760288A1 (sv)
DK (2) DK168863B1 (sv)
ES (5) ES456625A1 (sv)
HU (2) HU179016B (sv)
IE (1) IE44888B1 (sv)
MX (1) MX4658E (sv)
SE (2) SE437832B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE55406B1 (en) * 1982-08-07 1990-09-12 Tanabe Seiyaku Co Novel cephalosporin compounds and preparation thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093803A (en) * 1971-05-14 1978-06-06 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-, furyl- or pyridylacetamido)] cephalosporins
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
SE417968B (sv) * 1972-10-20 1981-04-27 Fujisawa Pharmaceutical Co Forfarande for framstellning av penamderivat
US4113940A (en) * 1973-03-15 1978-09-12 Fujisawa Pharmaceutical Co., Ltd. 7-amino 2-lower alkyl-2 or 3-cephem-4-carboxylic acid derivatives and processes for preparation thereof
JPS5119765A (en) * 1974-08-09 1976-02-17 Takeda Chemical Industries Ltd Aminochiazoorujudotaino seizoho
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4298606A (en) * 1974-12-19 1981-11-03 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins

Also Published As

Publication number Publication date
SE437832B (sv) 1985-03-18
ES476075A1 (es) 1979-05-16
AR218241A1 (es) 1980-05-30
ES476076A1 (es) 1979-05-16
ES467635A1 (es) 1979-09-01
DK139691A (da) 1991-07-25
IE44888B1 (en) 1982-05-05
AR222010A1 (es) 1981-04-15
CA1218054A (en) 1987-02-17
DK168863B1 (da) 1994-06-27
SE8302027L (sv) 1983-04-12
IE44888L (en) 1977-09-09
DK101477A (da) 1977-09-10
US4560765A (en) 1985-12-24
ES456625A1 (es) 1978-07-16
HU176455B (en) 1981-03-28
HU179016B (en) 1982-08-28
SE454988B (sv) 1988-06-13
ES476077A1 (es) 1979-05-16
DE2760288A1 (sv) 1985-05-09
MX4658E (es) 1982-07-19
DK139691D0 (da) 1991-07-25
SE8302027D0 (sv) 1983-04-12

Similar Documents

Publication Publication Date Title
DK343980A (da) 2,4,6-triiod-isophthalsyrederivater
SE442295B (sv) Forfarande for framstellning av 4-amino-5-en-hexansyra
DK343880A (da) 2,4,6-triiod-isophthalsyrederivater
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
SE443981B (sv) Analogiforfarande for framstellning av syn-isomerer av 3,7 disubstituerade 3-cefem-4-karboxylsyraforeningar
NL7902408A (nl) 3,7-digesubstitueerde-3-cefem-4-carbonzuurverbindingen en werkwijzen ter bereiding daarvan.
ZA773308B (en) Process for the preparation of 10,19-dihydro-vitamin d compounds
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
NO147186C (no) Fremgangsmaate for fremstilling av substituerte purinforbindelser
RO75589A (ro) Procedeu pentru prepararea 2,6-metan-2h-1-benzoxocinei
NO771870L (no) Fremgangsm}te for fremstilling av 3,4-dihydro-2-metyl-4-okso-2h-1,2-benzotiazin-3-karboksylsyre-1,1-dioksyd
SE426947B (sv) Forfarande for framstellning av 3,5,5-trimetyl-hexanoyl-ferrocen
DK549177A (da) Substituerede 2,1,3-benzothiadiazinforbindelser
NO774503L (no) Fremgangsmaate for fremstilling av oktahydro-indolo(2,3,a)-chinoliziner
SE426067B (sv) Forfarande for framstellning av 9-hydroxi-7,8,9,10-tetrahydro-6h-dibenso (b,d) pyraner och -pyranoner
SE434157B (sv) Forfarande for framstellning av 6-aminopenicillansyra
NO772809L (no) Fremgangsm}te for fremstilling av 2,6-diterti{rt-butylfenol
NO150157C (no) Fremgangsmaate til fremstilling av 6,11-dihydro-11-okso-dibenz(b,e)-oksepin-2-eddiksyre
SE7702547L (sv) Forfarande for framstellning av 3,7-disubstituerade 3-cefem-4-karboxylsyraforeningar
IT1087124B (it) Procedimento per preparare idrossi-4 alchil-4 cicloesadien-2,5 one-1
DK534976A (da) Substituerede 2,1,3-benzothiadiazin-forbindelser
RO74536A (ro) Procedeu pentru prepararea 2,3-dicloranisolului
NL7711480A (nl) Werkwijze ter bereiding van 3,5-dialkyl-4- -hydroxbenzoezuur.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7702547-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7702547-6

Format of ref document f/p: F